| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| TPG-C52H3 | Cynomolgus / Rhesus macaque | Cynomolgus / Rhesus macaque TPBG / 5T4 Protein, His Tag |  |
|
|
| TPG-M52H3 | Mouse | Mouse TPBG / 5T4 Protein, His Tag (MALS verified) |  |
|
|
| TPG-H5253 | Human | Human TPBG / 5T4 Protein, Fc Tag (MALS verified) |  |
|
|
| TPG-H52E5 | Human | Unconjugated Human TPBG / 5T4 Protein, His,Avitag™ |  |
|
|
| TPG-H82Eb | Human | Biotinylated Human TPBG / 5T4 Protein, His,Avitag™ |  |
|
|
Immobilized Human TPBG, Fc Tag (Cat. No. TPG-H5253) at 1 μg/mL (100 μL/well) can bind Anti-TPBG Antibody, Human IgG1 with a linear range of 0.5-8 ng/mL (QC tested).
The purity of Mouse TPBG, His Tag (Cat. No. TPG-M52H3) is more than 90% and the molecular weight of this protein is around 53-65 kDa verified by SEC-MALS.
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| SYD-1875 | SYD-1875 | Phase 1 Clinical | Synthon Bv | Solid tumours | Details |
| ASN-004 | ASN-004 | Phase 1 Clinical | Asana Biosciences | Ovarian Neoplasms; Carcinoma, Ovarian Epithelial; Colonic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| Prostate cancer vaccine, inactivated viral (University of Oxford) | Clinical | University Of Oxford | Prostatic Neoplasms | Details | |
| OXB-301 | OXB-301; SAR-109659 | Phase 3 Clinical | Oxford Biomedica | Carcinoma, Renal Cell; Prostatic Neoplasms | Details |
| Naptumomab estafenatox | TTS-CD3; ABR-217620 | Phase 2 Clinical | Active Biotech | Carcinoma, Renal Cell; Pancreatic Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| GEN-1044 | GEN-1044 | Phase 2 Clinical | Genmab | Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Neoplasms; Urinary Bladder Neoplasms; Prostatic Neoplasms; Uterine Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis | Details |
| Anti-5T4 CAR-raNK Cell Therapy | Phase 1 Clinical | Solid tumours | Details |
This web search service is supported by Google Inc.
A-Z
